4.6 Review

Uncovering the Exosomes Diversity: A Window of Opportunity for Tumor Progression Monitoring

期刊

PHARMACEUTICALS
卷 13, 期 8, 页码 -

出版社

MDPI
DOI: 10.3390/ph13080180

关键词

exosomes; cancer; liquid biopsy; tumor circulome; tumor monitoring; tumor derived exosomes hematological malignancies; minimal residual disease

资金

  1. GILEAD Fellowship 2018
  2. POR FES/FESR 2014-20-ATS ALCMEONE [cup J18C17000610006]
  3. MIUR-PRIN [2017MHJJ55_002]
  4. EU project [PON-AIM1897004-1]
  5. FSE-FESR PON-RI 2014-2020

向作者/读者索取更多资源

Cells can communicate through special messages in the bottle, which are recorded in the bloodstream inside vesicles, namely exosomes. The exosomes are nanovesicles of 30-100 nm in diameter that carry functionally active biological material, such as proteins, messanger RNA (mRNAs), and micro RNA (miRNAs). Therefore, they are able to transfer specific signals from a parental cell of origin to the surrounding cells in the microenvironment and to distant organs through the circulatory and lymphatic stream. More and more interest is rising for the pathological role of exosomes produced by cancer cells and for their potential use in tumor monitoring and patient follow up. In particular, the exosomes could be an appropriate index of proliferation and cancer cell communication for monitoring the minimal residual disease, which cannot be easily detectable by common diagnostic and monitoring techniques. The lack of unequivocal markers for tumor-derived exosomes calls for new strategies for exosomes profile characterization aimed at the adoption of exosomes as an official tumor biomarker for tumor progression monitoring.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据